Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126504841 | 12650484 | 1 | I | 20131212 | 20160810 | 20160815 | 20160815 | EXP | ES-ROCHE-1812182 | ROCHE | NOTARIO FERREIRA I, FERRER GONZALEZ M; MORALES GARRIDO P, GONZALEZ UTRILLA A, GARCIA SANCHEZ A, SOTO PINO M, SUERO ROSARIO E, CARO HERNANDEZ C, ANON ONATE I, PEREZ ALBALADEJO L AND CALIZ CALIZ R. TWO-YEAR EFFICACY OF TOCILIZUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE. REUMATOLOGIA CLINICA 2015 OCT 09;:-. | 66.09 | YR | F | Y | 0.00000 | 20160815 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126504841 | 12650484 | 1 | PS | Tocilizumab | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 125276 | 8 | MG/KG | SOLUTION FOR INFUSION | ||||||||
| 126504841 | 12650484 | 2 | SS | Rituximab | RITUXIMAB | 1 | Unknown | 103705 | |||||||||||
| 126504841 | 12650484 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | U | 0 | 20 | MG | /wk | |||||||
| 126504841 | 12650484 | 4 | SS | INFLIXIMAB | INFLIXIMAB | 1 | Unknown | U | 0 | ||||||||||
| 126504841 | 12650484 | 5 | SS | ETANERCEPT | ETANERCEPT | 1 | Unknown | U | 0 | ||||||||||
| 126504841 | 12650484 | 6 | SS | ADALIMUMAB | ADALIMUMAB | 1 | Unknown | U | 0 | ||||||||||
| 126504841 | 12650484 | 7 | SS | ABATACEPT | ABATACEPT | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126504841 | 12650484 | 1 | Rheumatoid arthritis |
| 126504841 | 12650484 | 2 | Rheumatoid arthritis |
| 126504841 | 12650484 | 3 | Rheumatoid arthritis |
| 126504841 | 12650484 | 4 | Rheumatoid arthritis |
| 126504841 | 12650484 | 5 | Rheumatoid arthritis |
| 126504841 | 12650484 | 6 | Rheumatoid arthritis |
| 126504841 | 12650484 | 7 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126504841 | 12650484 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126504841 | 12650484 | Drug ineffective | |
| 126504841 | 12650484 | Ovarian cancer metastatic |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126504841 | 12650484 | 1 | 20130904 | 20131212 | 0 | |
| 126504841 | 12650484 | 3 | 20130904 | 0 |